129 related articles for article (PubMed ID: 7670166)
1. Local immunomodulation to promote co-stimulatory blockade.
Chahine AA; Stoeckert C; Lau HT
Clin Transplant; 1995 Jun; 9(3 Pt 2):215-8. PubMed ID: 7670166
[No Abstract] [Full Text] [Related]
2. The CD28 and CTLA-4 receptor family.
June CH; Vandenberghe P; Thompson CB
Chem Immunol; 1994; 59():62-90. PubMed ID: 7945930
[No Abstract] [Full Text] [Related]
3. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
Zhou T; Weaver C; Linsley PS; Mountz JD
Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
[TBL] [Abstract][Full Text] [Related]
4. The B7/CD28/CTLA4 T-cell activation pathway. Implications for inflammatory lung disease.
Green JM
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):261-4. PubMed ID: 10696061
[No Abstract] [Full Text] [Related]
5. T-cell regulation by CD28 and CTLA-4.
Alegre ML; Frauwirth KA; Thompson CB
Nat Rev Immunol; 2001 Dec; 1(3):220-8. PubMed ID: 11905831
[TBL] [Abstract][Full Text] [Related]
6. T cell activation: you can't get good help.
Linsley PS
Nat Immunol; 2001 Feb; 2(2):139-40. PubMed ID: 11175808
[No Abstract] [Full Text] [Related]
7. Costimulation and its role in organ transplantation.
Bluestone JA
Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
[TBL] [Abstract][Full Text] [Related]
8. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
[TBL] [Abstract][Full Text] [Related]
9. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation.
Metz DP; Farber DL; Taylor T; Bottomly K
J Immunol; 1998 Dec; 161(11):5855-61. PubMed ID: 9834064
[TBL] [Abstract][Full Text] [Related]
10. The B7 and CD28 receptor families.
June CH; Bluestone JA; Nadler LM; Thompson CB
Immunol Today; 1994 Jul; 15(7):321-31. PubMed ID: 7522010
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD28 has a potent adjuvant effect on the antibody response to soluble antigens mediated through CTLA-4 by-pass.
Carlring J; Barr TA; Buckle AM; Heath AW
Eur J Immunol; 2003 Jan; 33(1):135-42. PubMed ID: 12594842
[TBL] [Abstract][Full Text] [Related]
12. When ligand becomes receptor--tolerance via B7 signaling on DCs.
Finger EB; Bluestone JA
Nat Immunol; 2002 Nov; 3(11):1056-7. PubMed ID: 12407416
[No Abstract] [Full Text] [Related]
13. Immunology. The immunological synapse--a multitasking system.
van Der Merwe PA; Davis SJ
Science; 2002 Feb; 295(5559):1479-80. PubMed ID: 11859183
[No Abstract] [Full Text] [Related]
14. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
Khattri R; Auger JA; Griffin MD; Sharpe AH; Bluestone JA
J Immunol; 1999 May; 162(10):5784-91. PubMed ID: 10229811
[TBL] [Abstract][Full Text] [Related]
15. Positive and negative regulation of human T cell activation mediated by the CTLA-4/CD28 ligand CD80.
Boulougouris G; McLeod JD; Patel YI; Ellwood CN; Walker LS; Sansom DM
J Immunol; 1998 Oct; 161(8):3919-24. PubMed ID: 9780158
[TBL] [Abstract][Full Text] [Related]
16. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
17. The ups and downs of T cell costimulation.
Jenkins MK
Immunity; 1994 Sep; 1(6):443-6. PubMed ID: 7534615
[No Abstract] [Full Text] [Related]
18. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.
Larsen CP; Elwood ET; Alexander DZ; Ritchie SC; Hendrix R; Tucker-Burden C; Cho HR; Aruffo A; Hollenbaugh D; Linsley PS; Winn KJ; Pearson TC
Nature; 1996 May; 381(6581):434-8. PubMed ID: 8632801
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance.
Steurer W; Nickerson PW; Steele AW; Steiger J; Zheng XX; Strom TB
J Immunol; 1995 Aug; 155(3):1165-74. PubMed ID: 7543517
[TBL] [Abstract][Full Text] [Related]
20. Turning on tumor-fighting T-cells. Two signals are better than one when it come to developing new cancer therapies.
Edgington SM
Biotechnology (N Y); 1993 Oct; 11(10):1117-9. PubMed ID: 7691094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
